Sparsentan
id:
sparsentan-184-1407079
title:
Sparsentan
text:
Sparsentan, sold under the brand name Filspari, is a medication used for the treatment of primary immunoglobulin A nephropathy. Sparsentan is an endothelin and angiotensin II receptor antagonist. It is taken by mouth. The most common side effects include swelling of the extremities, low blood pressure, dizziness, high blood potassium, anemia, injury to the kidney, and increased liver enzymes in the blood. It was approved for medical use in the United States in February 2023. The US Food and Drug
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Sparsentan
date created:
2023-02-17T22:54:08Z
date modified:
2024-09-07T02:25:49Z
main entity:
{"identifier":"Q116973655","url":"https://www.wikidata.org/entity/Q116973655"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/92/Sparsentan.svg","width":512,"height":487}
fields total:
13
integrity:
16